Breakthrough Phase 2 Trial Results Show Promise for Patients Ineligible for Standard Reperfusion TherapiesData Presented at International Stroke ConferenceData Show…
Nearly all participants (11 of 12) experienced clinically meaningful hearing improvements, including three who achieved normal hearing; eight with longer…
MUMBAI, India, July 11, 2025 /PRNewswire/ -- Dun & Bradstreet, a global leader in business decisioning data and analytics, has released…
AUSTIN, Texas, July 8, 2025 /PRNewswire/ -- Xojo, Inc., the creators of Xojo—a powerful cross-platform development tool and programming language—today…